VSA006

· Visirna Therapeutics HK Limited

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for VSA006, covering 2026-03-12 to 2026-03-12. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 2 Clinical Trial to Evaluate the Efficacy and Safety of VSA006 in Chinese NASH Patients [Phase 2]